Skip Navigation

VAERS Bibliography - July 2001

  1. Boulianne, N., De Serres, G., Duval, B., Shadmani, R., and Rochette, L. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000 Can.Commun.Dis.Rep. 5-15-2001, 27 (10): 85-90.
  2. Brayden, R. and France, E. K. Efficient vaccination practices Pediatr.Ann. 2001, 30 (5): 284-288.
  3. Buxton, J. A., Skowronski, D. M., Ng, H., Marion, S. A., Li, Y., King, A., and Hockin, J. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks J.Infect.Dis. 7-15-2001, 184 (2): 188-191.
  4. Dagan, R., Amir, J., Ashkenazi, S., Hardt, K., and Kaufhold, A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination Pediatr.Infect.Dis.J. 2001, 20 (6): 587-592.
  5. DeStefano, F. More evidence to reassure physicians and parents about vaccination West J.Med. 2001, 174 (6): 390-391.
  6. Earhart, K. C., Beadle, C., Miller, L. K., Pruss, M. W., Gray, G. C., Ledbetter, E. K., and Wallace, M. R. Outbreak of influenza in highly vaccinated crew of u.s. navy ship Emerg.Infect.Dis. 2001, 7 (3): 463-465.
  7. Fiechtner, H. B. and Falls, S. Vaccination myths and misconceptions S D.J.Med. 2001, 54 (5): 165-166.
  8. Griffin, J. P. MMR vaccination: how reassuring is reassurance? Adverse Drug React.Toxicol.Rev. 2001, 20 (1): 1-2.
  9. Hamilton, M. The MMR vaccination and autism: a lay person's contribution West Indian Med.J. 2001, 50 (1): 87-89.
  10. Hernandez-Suarez, C. M. A note on the distribution of the number of vaccinated infected under non-random mixing conditions Stat.Med. 7-15-2001, 20 (13): 1983-1986.
  11. Heyderman, R. Commentary: Should programmes for community-level meningococcal vaccination be considered in Australia-an economic evaluation Int.J.Epidemiol. 2001, 30 (3): 578-579.
  12. Houcke-Bruge, C., Delaporte, E., Catteau, B., Martin, De Lassalle, and Piette, F. [Granuloma annulare following BCG vaccination] Ann.Dermatol.Venereol. 2001, 128 (4): 541-544.
  13. Humiston, S. G. and Strikas, R. A. Routine childhood vaccination update: educating the office staff Pediatr.Ann. 2001, 30 (6): 329-341.
  14. Iwane, M. K. and Schwartz, B. Pediatric influenza immunization: should healthy children be vaccinated? Pediatr.Ann. 2001, 30 (6): 354-357.
  15. Kaji, M., Tsuru, T., and Oizumi, K. [Efficacy and safety of influenza vaccination to elderly patients with neurological diseases] Kansenshogaku Zasshi. 2001, 75 (5): 411-415. infection
  16. Vaccine. 7-16-2001, 19 (28-29): 4011-4019.
  17. Law, B. J. Chickenpox vaccination, not chickenpox, should be routine for Canadian children CMAJ. 5-15-2001, 164 (10): 1454-1455.
  18. De Los Rios, Martin R., Garcia, Marin N., Sanz, Moreno J., and Ballester, Orcal E. [Mumps in an urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures] Aten.Primaria. 6-15-2001, 28 (1): 10-16.
  19. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 37-50.
  20. Mollenkopf, H., Dietrich, G., and Kaufmann, S. H. Intracellular bacteria as targets and carriers for vaccination Biol.Chem. 2001, 382 (4): 521-532.
  21. Oh, J. KePRO priming for adult vaccination campaign Pa Med. 1999, 102 (11): 6.
  22. Russell, M. L. Influenza vaccination in Alberta long-term care facilities CMAJ. 5-15-2001, 164 (10): 1423-1427.
  23. Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Mshinda, H., and Alonso, P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial Lancet. 5-12-2001, 357 (9267): 1471-1477.
  24. Skull, S., Butler, J., Robinson, P., and Carnie, J. Should programmes for community-level meningococcal vaccination be considered in Australia? An economic evaluation Int.J.Epidemiol. 2001, 30 (3): 571-578.
  25. Watanabe, T. and Onda, H. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination Pediatr.Nephrol. 2001, 16 (5): 458-459. Yamazaki, T., Suzuki, T., and Yamamoto, K. Vaccinating Japanese schoolchildren against influenza N.Engl.J.Med. 6-21-2001, 344 (25): 1947-1948.

[top]

[top]